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Abstract 
Labeling of physiologically relevant molecules with no carrier added (n.c.a.) [18F]fluoride is performed 
with the aim of an application of these “radiotracers” in positron emission tomography. In order to find 18F-
labeled radioligands of the AMPA receptor on the basis of the urea structure, the first task of this work 
was to develop a synthesis of 4-[18F]fluorophenyl urea derivatives. 
A direct labeling of the electron rich, i.e. not activated, 4-fluorophenyl ureas by an SNAr-reaction is not 
possible. Thus, radiosyntheses involving three or four step procedures were developed. 
4-[18F]Fluoroaniline was produced in the first two steps, whose synthesis has already been described 
several times in the literature. All those concepts were combined to give an optimum method regarding 
efficiency and duration. The reaction of para-dinitrobenzene with n.c.a. [18F]fluoride, activated by the 
potassium-Kryptofix-complex, in DMSO at 120°C leads to 4-[18F]fluoronitrobenzene. For the subsequent 
reduction of the nitro-group, palladium (black) and phosphoric acid in methanol under reflux conditions 
proved to be the best system to yield 4-[18F]fluoroaniline. The time of synthesis until this step was 30 min 
with a radiochemical yield of at least 80%. 
Subsequent transformation to the 4-[18F]fluorophenyl ureas was performed via carbamate-4-
nitrophenylesters, whereas strategies involving isocyanate compounds failed. In general, reactions of 
carbamate-4-nitrophenylesters with an amine yielded the corresponding urea. Hence, two different ways 
for the radiosynthesis are possible. One is to produce the carbamate in a reaction of [18F]fluoroaniline with 
4-nitrophenyl chloroformate, followed by addition of an amine of choice. To avoid one radiosynthetic step, 
the [18F]fluoroaniline can alternatively be reacted directly with the 4-nitrophenyl carbamate of the amine. 
The yields of the [18F]fluorophenylcarbamate-4-nitrophenylester from [18F]fluoroaniline are nearby 
quantitative. Subsequent reaction with n-propyl amine, cyclo-hexyl amine, benzyl amine or aniline leads 
to the corresponding ureas with an overall radiochemical yield of more than 70%. The shorter 
radiosyntheses with [18F]fluoroaniline and phenylcarbamate, benzylcarbamate or cyclo-hexylcarbamate 
gave generally a lower RCY in the range of 50 to 70%. With the n-propylcarbamate nearly no conversion 
to the urea is detectable. 
A direct application of this general method to preparation of n.c.a. [18F]fluorophenyl ureas for the 
synthesis of two putative AMPA-receptor ligands of the quinoxalinedione-family (QX) failed. Even the 
synthesis of the stable reference substances was not successful. Therefore a change to less complex 
quinoxalinediones appeared necessary, and those labeling approaches led to success. Dinitro- and 
cyano-nitro-QX are established antagonists of the AMPA-receptor. The aromatic rings in these molecules 
are activated by the nitro- or cyano-group, respectively, for the SNAr-reaction with [18F]fluoride, whereas 
one nitro-group might function as leaving group. The relevant stable analogues fluoro-nitro-QX (FNQX) 
and fluoro-cyano-QX (FCQX) were synthesized as reference substances. The radiosynthesis of 
[18F]FNQX was performed with DNQX as precursor and Kryptofix-activation in DMSO at 180°C and a 
reaction time of 20 min. With the low RCY of 5 – 10% and a molar activity of 1.5 GBq/µmol there was 
enough labeled product for first pharmacological experiments. 18F-labeling of FCQX was only possible by 
an 18F-for-19F isotopic exchange reaction. Therefore, the [18F]FNQX contains carrier, and the RCY with 
about 5% is again very low. 
For the general evaluation of the affinity of FNQX and FCQX the stable reference substances were 
utilized in competition studies with tritiated AMPA in vitro. Their affinities in form of the inhibition constants 
Ki were determined with 1.4 µmol and 3.9 µmol, respectively, which are clearly lower than those of CNQX 
(0.5 µmol) or AMPA (0.06 µmol). Nevertheless, the general mode of structur-activity-relationship in QX-
derivatives could be affirmed by these studies. 
Blocking experiments with rat brain slices showed that the binding of [3H]AMPA or [18F]FNQX can be 
neither completely blocked by an excess of stable FNQX nor by an excess of stable FCQX. This is an 
evidence for a large fraction of unspecific binding of the ligand in brain tissue. Finally, the extremely low 
brain uptake of [18F]FNQX, which was determined in ex vivo examinations, led to the conclusion that 
these substances are not suited for radiopharmaceutical application of in vivo imaging.  
 
 
